Shifa Tahir

Shifa Tahir

Auto-generated profile, based on publicly available information

Shifa Tahir

Unité de Physiologie de la Reproduction et des Comportements, Institut National de la Recherche Agronomique, Université François Rabelais-Tours, CNRS, 37380 Nouzilly, France

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2018 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
TBthomas bourquard
thomas bourquard
AMAstrid Musnier
Astrid Musnier
VPVincent Puard
Vincent Puard
STShifa Tahir
Shifa Tahir
MAMohammed Akli Ayoub
Mohammed Akli Ayoub
APAnne Poupon
Anne Poupon
Abs are very efficient drugs, ∼70 of them are already approved for medical use, over 500 are in clinical development, and many more are in preclinical development. One important step in the characterization and protection of a therapeutic Ab is the determination of its cognate epitope. The gold standard is the three-dimensional structure of the Ab/Ag complex by crystallography or nuclear magnetic resonance spectroscopy. However, it remains a tedious task, and its outcome is uncertain. We have developed MAbTope, a docking-based prediction method of the epitope associated with straightforward experimental validation procedures. We show that MAbTope predicts the correct epitope for each of 129 tested examples of Ab/Ag complexes of known structure. We further validated this method through the successful determination, and experimental validation (using human embryonic kidney cells 293), of the epitopes recognized by two therapeutic Abs targeting TNF-α: certolizumab and golimumab.